Methylphenidate HCl | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Methylphenidate HCl
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Methylphenidate Hydrochloride

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Methylphenidate HCl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 20 USDMF, 16 CEP/COS, 1 JDMF, 5 EU WC, 8 KDMF, 20 NDC API, 15 Listed Suppliers, $ API Reference Price

42 API Suppliers
20 USDMF
16 CEP/COS
1 JDMF
5 EU WC
8 KDMF
20 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

44 Drugs in Development

44 Drugs in Development

FINISHED DOSAGE FORMULATIONS

625 FDF Dossiers, 262 FDA Orange Book, 232 Europe, 53 Canada, 34 South Africa, 44 Listed Dossiers

625 FDF Dossiers
262 FDA Orange Book
232 Europe
53 Canada
34 South Africa
44 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 18MG, TABLET, EXTENDED RELEASE;ORAL - 27MG, TABLET, EXTENDED RELEASE;ORAL - 36MG, TABLET, EXTENDED RELEASE;ORAL - 54MG, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, SOLUTION;ORAL - 10MG/5ML, SOLUTION;ORAL - 5MG/5ML, TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 20MG
TABLET;ORAL - 5MG
TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 15MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG
TABLET, EXTENDED RELEASE;ORAL - 18MG
TABLET, EXTENDED RELEASE;ORAL - 27MG
TABLET, EXTENDED RELEASE;ORAL - 36MG
TABLET, EXTENDED RELEASE;ORAL - 54MG
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
SOLUTION;ORAL - 10MG/5ML
SOLUTION;ORAL - 5MG/5ML
TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 6 Evonik, 8 Rochem International Inc, 20 SPI Pharma, 21 DKSH, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 8 Kirsch Pharma, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 38 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 20 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 2 Hayashibara, 13 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 36 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 6 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 3 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

93 Fillers, Diluents & Binders, 81 Coating Systems & Additives, 56 Thickeners and Stabilizers, 49 Controlled & Modified Release, 40 Direct Compression, 39 Taste Masking, 35 Granulation, 34 Solubilizers, 30 Film Formers & Plasticizers, 30 Topical, 29 Parenteral, 27 Disintegrants & Superdisintegrants, 26 Lubricants & Glidants, 24 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 11 Emulsifying Agents, 11 Rheology Modifiers, 9 Empty Capsules, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

93 Fillers, Diluents & Binders
81 Coating Systems & Additives
56 Thickeners and Stabilizers
49 Controlled & Modified Release
40 Direct Compression
39 Taste Masking
35 Granulation
34 Solubilizers
30 Film Formers & Plasticizers
30 Topical
29 Parenteral
27 Disintegrants & Superdisintegrants
26 Lubricants & Glidants
24 Chewable & Orodispersible Aids
12 Co-Processed Excipients
11 Emulsifying Agents
11 Rheology Modifiers
9 Empty Capsules
7 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 70 News #PharmaBuzz

2 Data Compilation #PharmaFlow
70 News #PharmaBuzz

GLOBAL SALES INFORMATION

47 US Medicaid Prescriptions, 150 Regulatory FDF Prices, 2 Annual Reports

47 US Medicaid Prescriptions
150 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

10 APIs, 2 FDF Dossiers

10 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

224 US Patents, 57 Health Canada Patents

224 US Patents
57 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 Others

3 EDQM
1 Others

$ API Ref.Price (USD/KG) : 683 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

53 All

01 8APOTEX INC

02 15ELVIUM LIFE SCIENCES

03 4JANSSEN INC

04 4KYE PHARMACEUTICALS INC.

05 11PHARMASCIENCE INC

06 7Pharmascience Inc.

07 4TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

53 All

01 46METHYLPHENIDATE HYDROCHLORIDE

02 7Methylphenidate Hydrochloride

filter Dosage Form Reset all filters

53 All

01 7CAPSULE (CONTROLLED RELEASE)

02 16CAPSULE (EXTENDED RELEASE)

03 1POWDER (EXTENDED RELEASE)

04 9TABLET

05 3TABLET (CHEWABLE, EXTENDED-RELEASE)

06 17TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

53 All

01 4ACT METHYLPHENIDATE ER

02 3APO-METHYLPHENIDATE

03 4APO-METHYLPHENIDATE ER

04 1APO-METHYLPHENIDATE SR

05 8BIPHENTIN

06 4CONCERTA

07 7FOQUEST

08 4PMS-METHYLPHENIDATE

09 8PMS-METHYLPHENIDATE CR

10 4PMS-METHYLPHENIDATE ER

11 1PMS-METHYLPHENIDATE TABLETS 10MG

12 1PMS-METHYLPHENIDATE TABLETS 20MG

13 3QUILLIVANT ER CHEWABLE TABLETS

14 1QUILLIVANT ER ORAL SUSPENSION

Veranova Methylphenidate Hydrochloride

List of Suppliers

Product Main Page

01

Pharmascience Inc.

iPHEX India

Not Confirmed

Pharmascience Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE TABLETS 10MG

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pharmascience Inc.

iPHEX India

Not Confirmed

Pharmascience Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE TABLETS 20MG

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pharmascience Inc.

iPHEX India

Not Confirmed

Pharmascience Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pharmascience Inc.

iPHEX India

Not Confirmed

Pharmascience Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 18MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Pharmascience Inc.

iPHEX India

Not Confirmed

Pharmascience Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 27MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pharmascience Inc.

iPHEX India

Not Confirmed

Pharmascience Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 36MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Pharmascience Inc.

iPHEX India

Not Confirmed

Pharmascience Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 54MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

PHARMASCIENCE INC

iPHEX India

Not Confirmed

PHARMASCIENCE INC

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100/500

Approval Date :

Application Number : 584991

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

PHARMASCIENCE INC

iPHEX India

Not Confirmed

PHARMASCIENCE INC

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 100

Approval Date :

Application Number : 585009

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

PHARMASCIENCE INC

iPHEX India

Not Confirmed

PHARMASCIENCE INC

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number : 2234749

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!